- CXCR4 inhibitor, AMD3100, down-regulates PARP1 expression and Synergizes with olaparib causing severe DNA damage in BRCA-proficient triple-negative breast cancer.
- Xie XF, Wu NQ, Wu JF, Zhang GL, Guo JF, Chen XL, Du CW.
- Cancer Lett. 2022 Oct 6:215944. doi: 10.1016/j.canlet.2022.215944. Epub ahead of print.
- PMID: 36209974
- PubMed abstract
- Source abstract